CleanNA has entered the molecular diagnostics market with the launch of its first CE-IVD-marked product, the Clean Cell Free DNA Kit.
Featuring magnetic bead technology, the new kit is suitable for automation and application in diagnostic procedures.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The kit is intended for isolating cell-free DNA from human plasma in a bind, wash and elute three-step concept.
It is said to be minimally invasive for the patient, as it requires only a blood sample rather than a surgical biopsy.
The new kit is applicable in oncology, transplant medicine, prenatal screening and cardiovascular disease fields.
The Clean Cell Free DNA Kit is the first product in a line of CE-IVD-marked offerings that the company aims to release in the coming years.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataCleanNA owner and CEO Glenn Nohar said: “The launch of the Clean Cell Free DNA Kit, our first CE-IVD product, marks a milestone for our company.
“Our hard work has led us to this moment and we are fully prepared to position CleanNA within the molecular diagnostics market.”
CleanNA, a Dutch manufacturer of magnetic bead-based nucleic acid extraction kits, has an EN-ISO 13485-certified quality management system.
The company’s product line consists of nucleic acid extraction kits that can be used in research and diagnostic applications.
They are also suitable for sample cleanup during polymerase chain reaction or next-generation sequencing procedures.
